|
|
Volumn 504, Issue 7480, 2013, Pages
|
|
Calling cells to ARMS
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BCG VACCINE;
CANCER ANTIBODY;
CANCER VACCINE;
INTERFERON;
IPILIMUMAB;
NIVOLUMAB;
RITUXIMAB;
SIPULEUCEL T;
TUMOR ANTIGEN;
VITESPEN;
MONOCLONAL ANTIBODY;
CANCER CELL;
CANCER COMBINATION CHEMOTHERAPY;
CANCER IMMUNIZATION;
CANCER PATIENT;
CANCER THERAPY;
CELL MATURATION;
CELL PROLIFERATION;
CELL THERAPY;
COLON CANCER;
CORYNEBACTERIUM;
DENDRITIC CELL;
HELPER CELL;
HUMAN;
IMMUNE SYSTEM;
IMMUNOCOMPETENT CELL;
IMMUNOMODULATION;
INNATE IMMUNITY;
KIDNEY CANCER;
LARGE CELL LYMPHOMA;
MELANOMA;
MEMORY T LYMPHOCYTE;
NONHUMAN;
NOTE;
PRIORITY JOURNAL;
PROSTATE CANCER;
REGULATORY T LYMPHOCYTE;
STREPTOCOCCUS PYOGENES;
TARGET CELL;
TUMOR CELL;
TUMOR MICROENVIRONMENT;
CANCER IMMUNOTHERAPY;
CYTOLOGY;
IMMUNE RESPONSE;
ANTIBODIES, MONOCLONAL;
CANCER VACCINES;
CLINICAL TRIALS, PHASE III AS TOPIC;
HISTORY, 19TH CENTURY;
HISTORY, 20TH CENTURY;
HISTORY, 21ST CENTURY;
HUMANS;
IMMUNITY, INNATE;
IMMUNOTHERAPY;
NEOPLASMS;
|
|
EID: 84890532733
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/504S2a Document Type: Note |
|
Times cited : (14)
|
|
References (0)
|
